Akhil Muthigi

Akhil Muthigi practices at Texas Children's Hospital - Mfm the Methodist Hospital - HOPD in Houston, Texas.

Akhil Muthigi's NPI, 1821523234, was assigned on April 23, 2017. Akhil Muthigi graduated from Wake Forest School of Medicine in 2016. Akhil Muthigi's Texas license number on file is U6027.

Akhil Muthigi's primary practice is Texas Children's Hospital - Mfm the Methodist Hospital - HOPD, at 6550 Fannin St, Houston, TX 77030.

Akhil Muthigi's primary practice is Texas Children's Hospital - Mfm the Methodist Hospital - HOPD in Houston, Texas. Akhil Muthigi is also affiliated with Houston Methodist Hospital. The medical group on file is Houston Methodist Specialty Physician Group. Dmand AI also links Akhil Muthigi to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Akhil Muthigi practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Akhil Muthigi's primary specialty in the NPI Registry, under taxonomy code 208800000X. Akhil Muthigi is board certified in urology by the American Board of Urology. Dmand AI has Akhil Muthigi's licenses on file in 4 states: Texas, Florida, District of Columbia and Virginia.

Dmand AI lists enlarged prostate among the conditions Akhil Muthigi treats.

CMS data shows 189 Medicare services from Akhil Muthigi across 5 procedure codes in 2024, for 127 Medicare patients. Medicare paid $18,066 for them. Every service was in an office.

CMS counts 127 Medicare patients who saw Akhil Muthigi in 2024. The largest group is 65 to 74, with 66 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Akhil Muthigi's median patient age at 46, with 0% women.

In 2024, Akhil Muthigi wrote 171 Medicare Part D claims for 75 patients. 92% of them were for generic drugs. CMS names the drug for 90 of them, across 4 drugs with 11 or more claims each, at $2,254 in total drug cost. In 2022, CMS named 13 claims across 1 drug.

Akhil Muthigi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Akhil Muthigi as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 59 papers to Akhil Muthigi, published from 2014 to 2025. 2016 was the busiest year, with 17. The most frequent topics are Prostatic Neoplasms, Magnetic Resonance Imaging and Image-Guided Biopsy. Akhil Muthigi has published most often in Int J Impot Res. Akhil Muthigi's most frequent co-authors are Ranjith Ramasamy, MD, Joshua Theodore White, MD, FRSCS and Bradford J. Wood, MD.

CMS Open Payments shows 106 general payments to Akhil Muthigi from 19 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 65% of the total. Boston Scientific Corporation paid the most, $5,315.

Akhil Muthigi graduated from Wake Forest School of Medicine in 2016.

Akhil Muthigi is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.